Paul L. Jenkinson, Chief Financial Officer at Kite Pharma, Inc. (KITE), sold 1,896 shares at $179.66 ($341K) on 2017-09-25, disclosed to the SEC on 2017-09-27.
Open-market sale of $341k KITE by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $179.66 | 948 | $170K | 50.0% |
| 2 | $179.66 | 948 | $170K | 50.0% |
| Total | $179.66 avg | 1,896 | $341K | 100% |